NDC 70518-3064-01 - Lovastatin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3064
- Requested NDC
- 70518-3064-01
- Package NDCs from labels
- 70518-3064-0, 70518-3064-1, 70518-3064-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lovastatin Tablets, USP Rx only | REMEDYREPACK INC. | 2026-04-03 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 70518-3064-0 | 2023-03-15 | Lovastatin Tablets, USP Rx only |
| 70518-3064-1 | 2023-03-15 | Lovastatin Tablets, USP Rx only |
| 70518-3064-0 | 2023-01-30 | Lovastatin Tablets, USP Rx only |
| 70518-3064-1 | 2023-01-30 | Lovastatin Tablets, USP Rx only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3064-0 | Lovastatin | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 6 | |
| 70518-3064-1 | Lovastatin | 30 in 1 BLISTER PACK | TABLET | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3064 | LOVASTATIN TABLET [REMEDYREPACK INC.] | 4 | Current NDC, Legacy NDC, 2 package rows | 20240312_a902a95f-072a-4487-99a9-109a93f8b23c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lovastatin | LOVASTATIN | Proficient Rx LP | c2b1b926-def3-4411-9aed-395b969028fe | 2021-01-01 | Warnings, Adverse reactions | 197903 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Teva Pharmaceuticals USA, Inc. | 0e15feec-d27e-4861-8152-c5a8b8ccacd4 | 2020-08-01 | Warnings, Adverse reactions | ANDA075551 0093-0928 197905 197904 197903 caf8172a-311b-447a-8c8b-e9d70c23c8e8 0e15feec-d27e-4861-8152-c5a8b8ccacd4 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Proficient Rx LP | 027bd594-6a0a-4e6d-bd3c-4f33fdb4166a | 2020-04-01 | Warnings, Adverse reactions | ANDA075551 197904 9LHU78OQFD |
| Lovastatin | LOVASTATIN | Proficient Rx LP | f9e27117-db98-48bc-b7bc-fc98c9b719cf | 2019-11-01 | Warnings, Adverse reactions | 197903 9LHU78OQFD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.